Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement.  Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.

MORE NEWS
  • 29Jul

    Microcoat at Pharmalab 2022

    Read More →
  • 22Jul

    EU innovation radar launches SciFiMed project- MicroCoat proud to be part of the project!

    Read More →
  • 05Mai

    Microcoat announces the 6th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 14Apr

    30 Years Microcoat

    Read More →
  • 10Mrz

    Donation handover Ahrtal

    Read More →
  • 21Okt

    We are back!

    Read More →
  • 07Okt

    Microcoat at BayernsBest50

    Read More →
  • 07Okt

    Job- und Ausbildungsmesse 14.10.2021 11:00 Uhr bis 21:00 Uhr in der Tiefenstollenhalle Peißenberg

    Read More →
  • 29Sep

    Job- und Ausbildungsmesse 05.10.2021 11:30 Uhr bis 21:00 Uhr in der Stadthalle Penzberg

    Read More →
  • 06Sep

    New trainees in September 2021

    Read More →